Co-Diagnostics ROA 2017-2024 | CODX

Current and historical return on assets (ROA) values for Co-Diagnostics (CODX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Co-Diagnostics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-12-31 $-0.04B $0.06B -50.00%
2024-09-30 $-0.04B $0.07B -50.15%
2024-06-30 $-0.04B $0.08B -40.86%
2024-03-31 $-0.04B $0.09B -38.61%
2023-12-31 $-0.04B $0.10B -33.18%
2023-09-30 $-0.04B $0.11B -37.23%
2023-06-30 $-0.04B $0.11B -30.34%
2023-03-31 $-0.03B $0.12B -23.32%
2022-12-31 $-0.01B $0.12B -9.29%
2022-09-30 $0.02B $0.15B 9.38%
2022-06-30 $0.03B $0.16B 18.09%
2022-03-31 $0.04B $0.17B 30.25%
2021-12-31 $0.04B $0.16B 32.80%
2021-09-30 $0.04B $0.11B 48.00%
2021-06-30 $0.05B $0.09B 62.67%
2021-03-31 $0.05B $0.08B 84.55%
2020-12-31 $0.04B $0.07B 92.97%
2020-09-30 $0.03B $0.06B 96.55%
2020-06-30 $0.01B $0.04B 61.54%
2020-03-31 $-0.01B $0.02B -77.42%
2019-12-31 $-0.01B $0.00B -141.18%
2019-09-30 $-0.01B $0.00B -141.18%
2019-06-30 $-0.01B $0.01B -150.00%
2019-03-31 $-0.01B $0.01B -184.62%
2018-12-31 $-0.01B $0.00B -240.00%
2018-09-30 $-0.01B $0.00B -184.62%
2018-06-30 $-0.01B $0.00B -200.00%
2018-03-31 $-0.01B $0.00B -228.57%
2017-12-31 $-0.01B $0.01B -290.91%
2017-06-30 $0.00B $0.00B 0.00%
2017-03-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Services $0.012B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.654B 26.76
Elevance Health (ELV) United States $95.024B 12.26
CVS Health (CVS) United States $84.108B 12.31
Cencora (COR) United States $56.754B 20.60
Natera (NTRA) United States $20.404B 0.00
DiDi Global (DIDIY) China $19.733B 29.00
BioMerieux (BMXMF) France $15.507B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.474B 0.00
ICON (ICLR) Ireland $12.230B 11.37
Solventum (SOLV) United States $11.439B 10.66
CochLear (CHEOY) Australia $11.362B 0.00
Revvity (RVTY) United States $11.225B 18.95
Doximity (DOCS) United States $10.619B 55.22
Viatris (VTRS) United States $10.051B 3.18
Medpace Holdings (MEDP) United States $8.864B 23.54
Avantor (AVTR) United States $8.852B 12.86
Sonic Healthcare (SKHHY) Australia $8.023B 0.00
HealthEquity (HQY) United States $7.414B 36.48
Charles River Laboratories (CRL) United States $5.826B 11.49
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.085B 24.08
Alignment Healthcare (ALHC) United States $3.503B 0.00
Organon (OGN) United States $3.361B 3.39
Sotera Health (SHC) United States $3.264B 18.85
BrightSpring Health Services (BTSG) United States $3.069B 31.87
Surgery Partners (SGRY) United States $2.814B 32.28
Concentras Parent (CON) United States $2.788B 14.50
Progyny (PGNY) United States $1.957B 43.09
GeneDx Holdings (WGS) United States $1.876B 73.46
Premier (PINC) United States $1.858B 11.90
Ardent Health Partners (ARDT) United States $1.817B 0.00
GoodRx Holdings (GDRX) United States $1.776B 38.58
Agilon Health (AGL) United States $1.759B 0.00
PACS (PACS) United States $1.468B 0.00
Teladoc Health (TDOC) United States $1.260B 0.00
Pediatrix Medical (MD) United States $1.105B 9.27
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
CareDx (CDNA) United States $0.938B 14.68
Establishment Labs Holdings (ESTA) $0.875B 0.00
AMN Healthcare Services Inc (AMN) United States $0.780B 6.17
Embecta (EMBC) United States $0.709B 4.86
Nutex Health (NUTX) United States $0.608B 11.91
QDM (QDMI) Hong Kong, SAR China $0.583B 0.00
Auna S.A (AUNA) Luxembourg $0.511B 13.55
Sonida Senior Living (SNDA) United States $0.438B 0.00
InnovAge Holding (INNV) United States $0.423B 0.00
Enhabit (EHAB) United States $0.405B 38.05
COMPASS Pathways (CMPS) United Kingdom $0.369B 0.00
SBC Medicals (SBC) United States $0.331B 0.00
LifeMD (LFMD) United States $0.324B 0.00
DocGo (DCGO) United States $0.227B 9.29
Oncology Institute (TOI) United States $0.187B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Beauty Health (SKIN) United States $0.124B 0.00
Sera Prognostics (SERA) United States $0.111B 0.00
Ascend Wellness Holdings (AAWH) United States $0.092B 0.00
OncoCyte (OCX) United States $0.088B 0.00
So-Young (SY) China $0.084B 0.00
Biodesix (BDSX) United States $0.078B 0.00
Basel Medical Group (BMGL) Singapore $0.075B 0.00
IceCure Medical (ICCM) Israel $0.070B 0.00
NeueHealth (NEUE) United States $0.057B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Pheton Holdings (PTHL) China $0.021B 0.00
ModivCare (MODV) United States $0.017B 5.95
SeaStar Medical Holding (ICU) United States $0.013B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00